EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

In silico based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches

Ahmad Fariz Maulana iD, Sriwidodo Sriwidodo iD, Iman Permana Maksum iD, Yaya Rukayadi iD

ADMET and DMPK · 06.03.2026 · 14 · 3070

DOI: 10.5599/admet.3070 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ADMET and DMPK, online erschienen am 06.03.2026. Verfasst von Ahmad Fariz Maulana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang, 45363, Indonesia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitas Padjadjaran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose: Diabetes mellitus type 2 is a global health issue marked by hyperglycemia and metabolic dysfunction. Despite progress, discovering safe and effective antidiabetic agents remains crucial. This review highlights integrated In Silico, In Vitro, and in vivo methods for identifying novel antidiabetic compounds from natural and synthetic origins. Experimental approach: Computational tools including molecular docking, molecular dynamics, and ADMET prediction identified inhibitors targeting DPP-IV, α-glucosidase, and PPAR. Promising compounds underwent in vitro enzymatic and cellular assays, followed by in vivo efficacy tests in diabetic animal models assessing glucose levels, biochemical markers, and tissue histopathology. Key results: Integrated computational and experimental approaches effectively pinpointed compounds with strong target binding, enzyme inhibition, and positive cellular effects. In vivo data showed significant glucose reduction, enhanced insulin response, and pancreatic protection. ADMET analysis further supported their drug-likeness and safety profiles. Conclusion: Combining computational screening with biological validations forms a cost-effective pipeline for antidiabetic drug discovery. Multi-disciplinary integration increases lead identification success, guiding future refinement of in silico models and expanded in vivo studies to accelerate novel diabetes therapeutic development.

Schlagwörter

Stichwörter der Autor:innen

ADMET predictiondrug discoveryin vitroin vivomultidisciplinary drug development

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Padjadjaran, Sumedang, 45363, Indonesia.
  • Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, 45363, Indonesia.
  • Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.

ORCID-Profile: Ahmad Fariz Maulana, Sriwidodo Sriwidodo, Iman Permana Maksum, Yaya Rukayadi

Förderung

  • Universitas Padjadjaran

Zitieren

APA

Maulana, A. F., Sriwidodo, S., Maksum, I. P., & Rukayadi, Y. (2026). In silico based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches. ADMET and DMPK, 14, 3070. https://doi.org/10.5599/admet.3070

Vancouver

Maulana AF, Sriwidodo S, Maksum IP, Rukayadi Y. In silico based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches. ADMET and DMPK. 2026;14:3070. doi:10.5599/admet.3070

BibTeX
@article{Maulana2026,
  author = {Maulana, Ahmad Fariz and Sriwidodo, Sriwidodo and Maksum, Iman Permana and Rukayadi, Yaya},
  title = {In silico based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches},
  journal = {ADMET and DMPK},
  year = {2026},
  volume = {14},
  pages = {3070},
  doi = {10.5599/admet.3070}
}
Kostenlos starten →